Grace Therapeutics share price logo

Grace Therapeutics

NASDAQ: GRCE

$1.86

+0.08

(+4.49%)

as on

Grace Therapeutics Stock Performance

as on November 7, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $1.79
    $1.89
    downward going graph

    3.76%

    Downside

    1.61%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.67
    $5.18
    downward going graph

    10.22%

    Downside

    178.49%

    Upside

    downward going graph

Grace Therapeutics share price movements today

Previous Close
$1.78
Open
$1.86
Volume
1.0M
Market Cap
$38.7M
Day's Low - High
$1.79 - $1.89
52 Week Low - High
$1.67 - $5.18

Grace Therapeutics Historical Returns

1 Month Return
-12.14 %
3 Month Return
-15.42 %
1 Year Return
-39.67 %
3 Year Return
0 %
5 Year Return
0 %

Grace Therapeutics Stock Fundamentals & Key Indicators

Check Grace Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$38.7M

EPS (TTM)

-1.2557

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.47

Industry PE ratio

-2.97

PEG Ratio

0.01

EBITDA

-25.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-35.78%

Grace Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Grace Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$38.7MNA-1.470.00%0.00%
Neutral$91.2B9.03%-28.63-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$99.4B52.18%20.7385.77%0.38%

Stock Returns calculator for Grace Therapeutics Stock including INR - Dollar returns

The Grace Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Grace Therapeutics investment value today

Current value as on today

₹65,662

Returns

-₹34,338

(-34.34%)

Returns from Grace Therapeutics Stock

-₹38,000 (-38%)

Dollar Impact

₹3,662 (+3.66%)

Analyst Recommendation on Grace Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Grace Therapeutics. Average target price of $4

Grace Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Grace Therapeutics.

Current Price

$1.86

Analyzed by

1 Analysts

High

$4

0

Low

$4

Grace Therapeutics target price $0, a slight upside of 0% compared to current price of $1.86. According to 1 analysts rating.

Indian Investors' Interest in Grace Therapeutics Stock

Search interest for Grace Therapeutics Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:33% versus previous 30 day period

Grace Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
-
Operating Income
-4
-6
-4
-5
-4
-3
-3
-3
-3
-15
EBITDA
-4
-6
-4
-5
-4
-3
-3
-3
-3
-15
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-4
-4
-
0
-3
-1
-3
-2
-15
Income Tax Expense
-1
0
0
0
-1
-
-
-
-1
-
Net Income
-4
-3
-3
-5
0
-3
-1
-3
-1
-15
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Grace Therapeutics Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
0
-
-
-
-
-
Gross Profit
-2
-2
-
-
0
-
-
-
-
-
Operating Income
-10
-15
-34
-48
-25
-19
-70
-17
-23
-11
EBITDA
-7
-14
-36
-47
-15
-19
-24
-15
-23
-11
Interest Expense
0
0
1
0
0
-
-
-
-
-
Depreciation
2
2
2
3
1
-
0
0
0
0
Income Before Tax
-10
-16
-39
-50
-31
-13
-70
-19
-18
-9
Income Tax Expense
0
-
-
-
-
0
-12
-2
-4
-1
Net Income
-10
-16
-39
-50
-31
-12
-57
-17
-13
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
61.22%
0.00%
0.00%
0.00%
0.00%
0.00%

Grace Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-2
-3
-4
0
-3
0
-2
-1
-15
Operating Cash Flow
-2
-3
-4
-4
-2
-1
-3
-2
-1
-3
Investing Cash Flow
6
0
-
0
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
14
0
0
4
0
-
Change in Cash
4
-3
-4
-4
11
-2
-3
1
-1
-3

Grace Therapeutics Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-10
-16
-39
-36
-24
-9
-42
-12
-9
-7
Operating Cash Flow
-6
-9
-24
-32
-17
-17
-15
-12
-14
-8
Investing Cash Flow
6
0
-9
11
-12
-3
13
0
-
-
Financing Cash Flow
6
8
45
18
74
-
0
7
14
3
Change in Cash
-2
-1
10
-3
46
-20
-2
-4
0
-5

Global Institutional Holdings in Grace Therapeutics

Check out the Institutions with significant holdings in Grace Therapeutics.

Funds
Holdings
Opaleye Management Inc.
14.43%
Vimal Kavuru
6.24%
VANGUARD INDEX FUNDS
1.90%
Vanguard
1.90%
Kohli Prashant
0.58%

Insights on Grace Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 892.4% return, outperforming this stock by 933.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 235.0% return, outperforming this stock by 262.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GRCE stock has moved down by -8.2%

About Grace Therapeutics

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
OrganisationGrace Therapeutics
Headquarters103 Carnegie Center, Princeton, NJ, 08540, US
IndustryBiotechnology
CEOPrashant Kohli

Key Management of Grace Therapeutics

Name

Title

Mr. Prashant Kohli

CEO & Director

Mr. Amresh Kumar Ph.D.

VP of Program Management

Ms. Carrie D'Andrea

Consultant

Mr. Robert J. DelAversano CPA

VP of Finance and Principal Financial & Accounting Officer

Dr. R. Loch MacDonald M.D., Ph.D.

Member of Scientific Advisory Board & Chief Medical Officer

FAQs

What is Grace Therapeutics share price today?

Grace Therapeutics share price today is $1.86 as on at the close of the market. Grace Therapeutics share today touched a day high of $1.89 and a low of $1.79.

What is the 52 week high and 52 week low for Grace Therapeutics share?

Grace Therapeutics share touched a 52 week high of $5.18 on and a 52 week low of $1.67 on . Grace Therapeutics stock price today i.e. is closed at $1.86,which is 64.09% down from its 52 week high and 11.38% up from its 52 week low.

What is Grace Therapeutics's market capitalisation today?

Grace Therapeutics market capitalisation is $0.00T as on .

How to invest in Grace Therapeutics Stock (GRCE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Grace Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Grace Therapeutics Stock (GRCE) from India?

Indian investors can start investing in Grace Therapeutics (GRCE) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in Grace Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Grace Therapeutics share’s latest price of $1.86 as on November 7, 2026 at 2:29 am IST, you will get 5.3763 shares of Grace Therapeutics. Learn more about fractional shares .